🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of this study is to determine whether zoledronic acid...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2003-09
Trial ID
NCT00181584
Treatments Being Tested
The primary purpose of this study is to evaluate the effect of the up-titra...
Status
Completed
Location
SGS Clinical Pharmacology Unit (located in ZNA Stuivenberg)
Start Date
2019-03-20
Trial ID
NCT03882255
Treatments Being Tested
The primary objective of this study is to test the hypothesis that myocardi...
Status
Completed
Location
Weatherhead PET Center for Preventing and Reversing Atherosclerosis, UT Medical School, Memorial Hermann Hospital
Start Date
2009-06
Trial ID
NCT00738049
Treatments Being Tested
The current available treatments for PTSD are not fully effective for cogni...
Status
Completed
Location
Ralph H. Johnson VA Medical Center, Charleston, SC
Start Date
2014-10-15
Trial ID
NCT02287038
Treatments Being Tested
The goal of this clinical trial is to compare the administration of 2 drugs...
Status
Not Yet Recruiting
Location
Isfahan University of Medical Sciences, Feiz Hospital, Isfahan
Start Date
2024-10-30
Trial ID
NCT06624384
Treatments Being Tested
This study is a single center, randomized, open/double-blind, placebo-contr...
Status
Unknown
Location
Huashan Hospital Fudan University
Start Date
2024-03-12
Trial ID
NCT06285227
Treatments Being Tested
Pregnancy rates for women over 35 years old are significantly lower when co...
Status
Completed
Location
REACh
Start Date
2014-04
Trial ID
NCT02119117
This study evaluates the safety and tolerability of treatment with K0706 in...
Status
Terminated
Location
MedStar Georgetown University Hospital
Start Date
2019-09-05
Trial ID
NCT03996460
Treatments Being Tested
Depressed patients will receive 6 weeks of citaloprma (20-40mg) therapy. Su...
Status
Completed
Location
Multiple Locations
Start Date
2005-02
Trial ID
NCT00593879
Treatments Being Tested
* Determine whether VI-0521 has an effect on the electrical activity of the...
Status
Completed
Location
MDS Pharma Services
Start Date
2009-02
Trial ID
NCT00839891
Treatments Being Tested